Showing results (111-120 of 192) with videos related to
Sort By:
Pageof 20
American Journal of Clinical Oncology|June 2, 2023
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid TumorsPaula M Fracasso, George A Fisher, Sherry A Goodner, et al.Biomedical Chromatography : BMC|April 4, 2017
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasmaGuillemette E Benoist, Eric van der Meulen, Floor J E Lubberman, et al.Pharmacotherapy|February 11, 2022
A dose-escalation clinical trial of intranasal ketamine for uncontrolled cancer-related painVinita Singh, Theresa W Gillespie, Olabisi Lane, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemiaIvana Gojo, Ming Tan, Hong-Bin Fang, et al.Journal of the National Cancer Institute|August 4, 2012
Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse modelShivendra V Singh, Su-Hyeong Kim, Anuradha Sehrawat, et al.Toxicology and Applied Pharmacology|May 8, 2025
Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiationJoshua J Deppas, Brian F Kiesel, Jianxia Guo, et al.Therapeutic Drug Monitoring|May 11, 2017
Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug MonitoringDaniel Kozo, Matt W Ross, Justin Jarrah, et al.Oncology Research|May 24, 2014
Clove extract inhibits tumor growth and promotes cell cycle arrest and apoptosisHaizhou Liu, John C Schmitz, Jianteng Wei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studySuresh S Ramalingam, Shivaani Kummar, John Sarantopoulos, et al.Cancer Chemotherapy and Pharmacology|October 31, 2013
Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteersHussein Tawbi, Susan M Christner, Yan Lin, et al.Pageof 20